Product Description
Grass Pollen Allergy Vaccine (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01538979)
Mechanisms of Action: Vaccine
Novel Mechanism: No
Modality: Vaccine
Route of Administration: Subcutaneous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Biomay AG
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Environmental Hypersensitivity|Animal Hypersensitivity|Grass Pollen Hypersensitivity|Rhinitis, Allergic, Seasonal|Hepatitis B
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
2015-004551-43 |
2015-004551-43 | P2 |
Completed |
Environmental Hypersensitivity|Grass Pollen Hypersensitivity |
2016-11-17 |
2022-03-13 |
Treatments |
|
NCT02643641 |
CS-BM32-004 | P2 |
Completed |
Environmental Hypersensitivity|Grass Pollen Hypersensitivity|Animal Hypersensitivity |
2016-10-01 |
2019-03-20 |
Treatments |
|
NCT01538979 |
CS-BM32-003 | P2 |
Completed |
Environmental Hypersensitivity|Rhinitis, Allergic, Seasonal|Grass Pollen Hypersensitivity |
2014-12-01 |
2019-03-19 |
||
2012-004194-12 |
2012-004194-12 | P2 |
Completed |
Grass Pollen Hypersensitivity|Environmental Hypersensitivity |
2014-11-21 |
2022-03-13 |
Treatments |
|
2012-000442-35 |
2012-000442-35 | P2 |
Completed |
Environmental Hypersensitivity|Grass Pollen Hypersensitivity |
2014-11-18 |
2022-03-13 |
Treatments |
|
2011-003368-64 |
2011-003368-64 | P2 |
Completed |
Environmental Hypersensitivity|Grass Pollen Hypersensitivity |
2012-04-19 |
2022-03-13 |
Treatments |
|
NCT01445002 |
CS-BM32-002 | P2 |
Completed |
Grass Pollen Hypersensitivity|Environmental Hypersensitivity|Rhinitis, Allergic, Seasonal |
2012-03-01 |
2019-03-19 |
Treatments |
|
NCT01350635 |
CS-BM32-001 | P2 |
Completed |
Grass Pollen Hypersensitivity|Hepatitis B|Environmental Hypersensitivity |
2011-07-01 |
2019-03-19 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
07/13/2022 |
PubMed |
Grain Structure Engineering of NiTi Shape Memory Alloys by Intensive Plastic Deformation. |
|
09/10/2021 |
PubMed |
Twin boundary migration in an individual platinum nanocrystal during catalytic CO oxidation. |
|
08/24/2021 |
News Article |
Grass Pollen Allergy Drugs In Development, 2021 Pipeline Landscape Report - ResearchAndMarkets.com |
|
07/27/2021 |
PubMed |
Grain boundary formation through particle detachment during coarsening of nanoporous metals. |